The Y axis shows the different therapies patients were maintained on during the 12 month period after a relapse. Each symbol is the maximal IL-33 expression of an individual patient on a specified DMT.</p
Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) effectin...
†<p>Mean (±SD).</p>§<p>Median (range).</p><p>The annualized relapse rate (ARR) during the last year ...
Multiple sclerosis (MS) is a life-long, potentially debilitating disease of the central nervous syst...
(a) Profile of IL-33 in patients showing highest level of expression of IL-33 at month 0, month 6–9 ...
(a-d) Longitudinal analysis of expression of IL-33 in each individual RRMS patients following a radi...
Correlation of IL-33 expression with expression of HDAC3 (left panel) or HDAC1 (right panel). The da...
a)IL-33 levels are correlated with expression of multiple genes during MS relapse and remission. mRN...
(Bolded numbers represent the group of patients who had the highest expression of IL-33 during the t...
IL-33 expression levels were determined by PCR and normalized to expression levels of GAPDH. The X-a...
ObjectiveWe tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to ref...
OBJECTIVE:We tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to re...
<p>The combinations of biomarkers were down or up-regulated simultaneously in the individuals. The r...
Cytokines are implicated in the immunopathogenesis of multiple sclerosis (MS). Interleukin (IL)-33, ...
Flow cytometric study on the expression of IL-33 in CD14+ and CD14- population of PBMC at different ...
<p>The levels of plasma and CSF IL-21 in individual subjects were tested by ELISA. (A) The levels of...
Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) effectin...
†<p>Mean (±SD).</p>§<p>Median (range).</p><p>The annualized relapse rate (ARR) during the last year ...
Multiple sclerosis (MS) is a life-long, potentially debilitating disease of the central nervous syst...
(a) Profile of IL-33 in patients showing highest level of expression of IL-33 at month 0, month 6–9 ...
(a-d) Longitudinal analysis of expression of IL-33 in each individual RRMS patients following a radi...
Correlation of IL-33 expression with expression of HDAC3 (left panel) or HDAC1 (right panel). The da...
a)IL-33 levels are correlated with expression of multiple genes during MS relapse and remission. mRN...
(Bolded numbers represent the group of patients who had the highest expression of IL-33 during the t...
IL-33 expression levels were determined by PCR and normalized to expression levels of GAPDH. The X-a...
ObjectiveWe tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to ref...
OBJECTIVE:We tested the hypothesis that the expression of IL-33 in MS is dynamic and is likely to re...
<p>The combinations of biomarkers were down or up-regulated simultaneously in the individuals. The r...
Cytokines are implicated in the immunopathogenesis of multiple sclerosis (MS). Interleukin (IL)-33, ...
Flow cytometric study on the expression of IL-33 in CD14+ and CD14- population of PBMC at different ...
<p>The levels of plasma and CSF IL-21 in individual subjects were tested by ELISA. (A) The levels of...
Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) effectin...
†<p>Mean (±SD).</p>§<p>Median (range).</p><p>The annualized relapse rate (ARR) during the last year ...
Multiple sclerosis (MS) is a life-long, potentially debilitating disease of the central nervous syst...